JG
PRAH

Joel Greenblatt’s PRA Health Sciences, Inc. PRAH Stock Holding History

Joel Greenblatt’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,129
Closed -$267K – 1141
2020
Q4 		$267K Sell
2,129
-1,772
-45% -$198K 0.01% 862
2020
Q3 		$396K Hold
3,901
– – 0.01% 786
2020
Q2 		$380K Sell
3,901
-3,451
-47% -$321K 0.01% 813
2020
Q1 		$611K Buy
7,352
+809
+12% +$78.9K 0.02% 672
2019
Q4 		$727K Sell
6,543
-171
-3% -$17.6K 0.01% 698
2019
Q3 		$666K Sell
6,714
-38,330
-85% -$3.81M 0.01% 679
2019
Q2 		$4.47M Sell
45,044
-1,429
-3% -$136K 0.07% 338
2019
Q1 		$5.13M Sell
46,473
-16,970
-27% -$1.77M 0.08% 339
2018
Q4 		$5.83M Sell
63,443
-38,794
-38% -$3.93M 0.09% 303
2018
Q3 		$11.3M Buy
102,237
+70,796
+225% +$7.37M 0.16% 197
2018
Q2 		$2.94M Sell
31,441
-33,694
-52% -$2.9M 0.04% 421
2018
Q1 		$5.4M Buy
65,135
+26,659
+69% +$2.37M 0.08% 344
2017
Q4 		$3.5M Buy
38,476
+31,670
+465% +$2.63M 0.05% 407
2017
Q3 		$518K Sell
6,806
-74,256
-92% -$5.61M 0.01% 695
2017
Q2 		$6.08M Sell
81,062
-63,941
-44% -$4.43M 0.09% 322
2017
Q1 		$9.46M Sell
145,003
-58,156
-29% -$3.43M 0.12% 274
2016
Q4 		$11.2M Buy
203,159
+1,658
+0.8% +$91K 0.14% 231
2016
Q3 		$11.4M Buy
201,501
+18,512
+10% +$908K 0.15% 217
2016
Q2 		$7.64M Buy
182,989
+42,311
+30% +$1.95M 0.09% 324
2016
Q1 		$6.01M Buy
140,678
+114,194
+431% +$4.83M 0.07% 395
2015
Q4 		$1.2M Buy
26,484
+9,306
+54% +$391K 0.01% 580
2015
Q3 		$667K Buy
17,178
+2,889
+20% +$116K 0.01% 688
2015
Q2 		$519K Buy
+14,289
New +$452K ﹤0.01% 727

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Joel Greenblatt's PRAH Position: Q1 2021 in Review

Joel Greenblatt sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 2,129 shares — an estimated $267K sold.

Joel Greenblatt first reported a position in PRAH in Q2 2015 and held it in 23 quarters. The position peaked at $11.4M in Q3 2016. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Joel Greenblatt reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Joel Greenblatt sold 2,129 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $267K.
  • Joel Greenblatt first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 23 quarters.
  • Joel Greenblatt's PRA Health Sciences, Inc. position peaked at $11.4M in Q3 2016.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Gotham Asset Management's 13F filing for Q1 2021, filed 17 May 2021.